| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.4 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |